Diabetes medication may protect against glaucoma
Researchers have reported that a common type of diabetes medication, GLP-1R agonists, may lower eye disease risk
Scientists from the University of Pennsylvania examined data relating to 1961 diabetic patients who had recently started taking GLP-1R agonists. They compared this information to the records of 4371 diabetic patients who were not taking this class of medication.
After 150 days, 0.5% of patients taking the medication had developed glaucoma, compared to 1.3% of patients developing the eye disease in the control group.
The authors highlighted: “Our findings support further investigations into the use of GLP-1R agonists in glaucoma prevention.”
The research is supported by another study in 2020 which revealed that this type of medication reduced neuroinflammation and prevented retinal ganglion cell death in mice.